vimarsana.com
Home
Live Updates
Ensysce Biosciences, Inc.: Ensysce Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results : vimarsana.com
Ensysce Biosciences, Inc.: Ensysce Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results
~ Corporate Update Call to be Held Tuesday, April 11, 2023 ~SAN DIEGO, CA / ACCESSWIRE / March 30, 2023 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC), a clinical-stage biotech
Related Keywords
Miami ,
Florida ,
United States ,
Canada ,
Ensysce Biosciences ,
Lynn Kirkpatrick ,
Dave Humphrey ,
Shannon Devine ,
William Schmidt ,
Vince Clinical Research ,
Solution Is Co ,
Ensysce Biosciences Inc ,
Quotient Sciences ,
Ensysce Biosciences Inc View ,
Ensysce Biosciences Company Contact ,
Overdose Protection Program Updates ,
Tm Opioid Abuse Deterrent Program Updates ,
Research Development Expenses ,
Corporate Update Call ,
Held Tuesday ,
Chief Executive Officer ,
Next Generation ,
Opioid Abuse Deterrent Program ,
Activated Abuse ,
Human Abuse Potential ,
Crossover Study ,
Oral Abuse Potential ,
Oxycodone Immediate Release Tablets ,
Non Dependent Recreational Opioid User ,
Vince Clinical ,
Trypsin Activated Abuse Protection ,
Opioid Abuse Deterrent ,
Overdose Protection Program ,
Multi Pill Abuse Resistance ,
Maria Bermudez ,
Single Dose Study ,
Immediate Release Solution ,
Capsule Formulations ,
Healthy Subjects ,
Development Expenses ,
Administrative Expenses ,
Consolidated Statements ,
Months Ended December ,
Ended December ,
Private Securities Litigation Reform Act ,
Biosciences Company Contact ,
Biosciences Investor Relations Contact ,
Ensysce ,
Iosciences ,
Reports ,
Fourth ,
Quarter ,
Bull ,
Ear ,
022 ,
Financial ,
Results ,
vimarsana.com © 2020. All Rights Reserved.